Literature DB >> 21934714

Involvement of surfactant protein D in emphysema revealed by genetic association study.

Takeo Ishii1, Koichi Hagiwara, Koichiro Kamio, Shinobu Ikeda, Tomio Arai, Makiko Naka Mieno, Toshio Kumasaka, Masaaki Muramatsu, Motoji Sawabe, Akihiko Gemma, Kozui Kida.   

Abstract

Surfactant protein D (SFTPD) induces emphysema in knockout mice, but the association of SFTPD with chronic obstructive pulmonary disease (COPD) and emphysema in humans is unclear. Therefore, we aimed to determine the association between genetic variations in SFTPD and susceptibility to COPD and emphysema.Two populations were studied: population A comprised 270 smokers, including 188 COPD and 82 at-risk subjects, and population B comprised 1131 autopsy cases including 160 cases with emphysema. Six single-nucleotide polymorphisms (SNPs) that tagged the linkage disequilibrium blocks on the entire SFTPD gene were genotyped; the associations of the genotypes with COPD, pulmonary function, percentage of the low-attenuation area (LAA%), and percentage of the airway wall area (WA%) were determined in population A. In population B, the associations of the genotypes with emphysema were assessed.A C allele at SNP rs721917 that results in the replacement of Met with Thr at position 11 in SFTPD was positively correlated with the LAA% in the upper lung (P = 1.1 × 10(-5)) and overall LAA% (P = 1.0 × 10(-4)), and negatively correlated with the serum concentration of SFTPD (P = 7 × 10(-11)) in the population A. The C/C (rs721917/rs10887199) haplotype was associated with emphysema in both the populations.Subjects with a C allele at rs721917 have a lower serum SFTPD concentration and are more susceptible to emphysema. This suggests a protective effect of SFTPD against COPD and emphysema.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934714      PMCID: PMC3260918          DOI: 10.1038/ejhg.2011.183

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  30 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.

Authors:  Dale R Nyholt
Journal:  Am J Hum Genet       Date:  2004-03-02       Impact factor: 11.025

3.  Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.

Authors:  Marilyn G Foreman; Xiangyang Kong; Dawn L DeMeo; Sreekumar G Pillai; Craig P Hersh; Per Bakke; Amund Gulsvik; David A Lomas; Augusto A Litonjua; Steven D Shapiro; Ruth Tal-Singer; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

4.  Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.

Authors:  S E Wert; M Yoshida; A M LeVine; M Ikegami; T Jones; G F Ross; J H Fisher; T R Korfhagen; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Morphopathology of chronic pulmonary emphysema.

Authors:  A Yamanaka
Journal:  Acta Pathol Jpn       Date:  1965-02

6.  Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function.

Authors:  Y Nakano; S Muro; H Sakai; T Hirai; K Chin; M Tsukino; K Nishimura; H Itoh; P D Paré; J C Hogg; M Mishima
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

7.  Complementation of pulmonary abnormalities in SP-D(-/-) mice with an SP-D/conglutinin fusion protein.

Authors:  Liqian Zhang; Kevan L Hartshorn; Erika C Crouch; Machiko Ikegami; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

8.  Centrilobular emphysema and panlobular emphysema: two different diseases.

Authors:  A E Anderson; A G Foraker
Journal:  Thorax       Date:  1973-09       Impact factor: 9.139

Review 9.  Alpha-1 antitrypsin deficiency with severe pulmonary emphysema.

Authors:  Akira Saito; Hajime Takizawa; Makoto Sato; Kenji Suzuki; Tadayuki Miyata; Tatsuyuki Tazawa; Toshihiro Nukiwa; Yutaka Morita
Journal:  Intern Med       Date:  2004-03       Impact factor: 1.271

10.  Clinical phenotypes of COPD: results of a Japanese epidemiological survey.

Authors:  Koichiro Tatsumi; Yasunori Kasahara; Katsushi Kurosu; Nobuhiro Tanabe; Yuichi Takiguchi; Takayuki Kuriyama
Journal:  Respirology       Date:  2004-08       Impact factor: 6.424

View more
  13 in total

1.  Age-related increases in ozone-induced injury and altered pulmonary mechanics in mice with progressive lung inflammation.

Authors:  Angela M Groves; Andrew J Gow; Christopher B Massa; LeRoy Hall; Jeffrey D Laskin; Debra L Laskin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-30       Impact factor: 5.464

2.  Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers.

Authors:  Marianne Samir M Issac; Wafaa Ashur; Heba Mousa
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

Review 3.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

4.  OSCAR is a receptor for surfactant protein D that activates TNF-α release from human CCR2+ inflammatory monocytes.

Authors:  Alexander D Barrow; Yaseelan Palarasah; Mattia Bugatti; Alex S Holehouse; Derek E Byers; Michael J Holtzman; William Vermi; Karsten Skjødt; Erika Crouch; Marco Colonna
Journal:  J Immunol       Date:  2015-02-25       Impact factor: 5.422

5.  Genetic studies as a tool for identifying novel potential targets for treatment of COPD.

Authors:  Ani Manichaikul; Jennifer N Nguyen
Journal:  Eur Respir J       Date:  2017-11-30       Impact factor: 16.671

Review 6.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

7.  A novel candidate region for genetic adaptation to high altitude in Andean populations.

Authors:  Guido Valverde; Hang Zhou; Sebastian Lippold; Cesare de Filippo; Kun Tang; David López Herráez; Jing Li; Mark Stoneking
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

8.  Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.

Authors:  Yasushi Horimasu; Noboru Hattori; Nobuhisa Ishikawa; Sonosuke Tanaka; Francesco Bonella; Shinichiro Ohshimo; Josune Guzman; Ulrich Costabel; Nobuoki Kohno
Journal:  BMC Med Genet       Date:  2014-01-08       Impact factor: 2.103

Review 9.  Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.

Authors:  Sofie Lock-Johansson; Jørgen Vestbo; Grith Lykke Sorensen
Journal:  Respir Res       Date:  2014-11-25

Review 10.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.